Nicox S.A. (EPA:ALCOX)
0.3680
-0.0090 (-2.39%)
Jun 23, 2026, 5:35 PM CET
Nicox Market Cap
Nicox has a market cap or net worth of €32.43 million as of June 23, 2026. Its market cap has increased by 111.52% in one year.
Market Cap
32.43M
Enterprise Value
28.69M
Revenue
16.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.37
Market Cap Chart
Since November 3, 1999, Nicox's market cap has decreased from 260.94M to 32.43M, a decrease of -87.57%. That is a compound annual growth rate of -7.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 32.43M | 34.48% |
| Dec 31, 2025 | 24.12M | 24.81% |
| Dec 31, 2024 | 19.32M | -12.36% |
| Dec 29, 2023 | 22.05M | -60.51% |
| Dec 30, 2022 | 55.83M | -49.18% |
| Dec 31, 2021 | 109.84M | -31.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adocia | 80.42M |
| OSE Immunotherapeutics | 79.83M |
| ABIONYX Pharma | 78.35M |
| MaaT Pharma | 52.01M |
| Fermentalg | 46.01M |
| THX Pharma Société Anonyme | 45.39M |
| genOway Société anonyme | 22.13M |
| GenSight Biologics | 18.64M |